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Central to the pathogenesis ofAlzheimer disease is the aberrant
processing of the amyloid precursor protein (APP) to generate
amyloid -peptide (A), the principle component of amyloid
plaques. The cell fate determinant Numb is a phosphotyrosine
binding domain (PTB)-containing endocytic adapter protein that
interacts with the carboxyl-terminal domain of APP. The physio-
logical relevanceof this interaction isunknown.Mammalsproduce
four alternatively spliced variants ofNumb that differ in the length
of their PTB and proline-rich region. In the current study, we
determined the influenceof the fourhumanNumbisoformson the
intracellular trafficking and processing of APP. Stable expression
ofNumb isoforms that differ in thePTBbutnot in theproline-rich
region results in marked differences in the sorting of APP to the
recycling anddegradativepathways.Neural cells expressingNumb
isoforms that lack the insert in the PTB (short PTB (SPTB)) exhib-
itedmarked accumulation of APP in Rab5A-labeled early endoso-
mal and recycling compartments, whereas those expressing iso-
forms with the insertion in the PTB (long PTB (LPTB)) exhibited
reduced amounts of cellular APP and its proteolytic derivatives
relative toparental control cells.Neither theactivities of the- and
-secretases nor the expression of APP mRNA were significantly
different in the stably transfected cells, suggesting that the differ-
ential effects of the Numb proteins onAPPmetabolism is likely to
besecondary toalteredAPPtrafficking. Inaddition, theexpression
of SPTB-Numb increases at the expense of LPTB-Numb in neuro-
nal cultures subjected to stress, suggesting a role for Numb in
stress-induced A production. Taken together, these results sug-
gest distinct roles for the human Numb isoforms in APPmetabo-
lismandmayprovide a novel potential link between alteredNumb
isoform expression and increased A generation.
The amyloid precursor protein (APP)2 is an integral trans-
membrane glycoprotein that is highly expressed in the brain
and plays an important role in neuronal function (1). The
abnormal processing of APP to generate the amyloid -pep-
tide (A) leads to the extracellular neuritic plaques charac-
teristic of Alzheimer disease (AD) (1–3). The rate of A
production is believed to be a key determinant of the onset
and progression of AD. Although proteolytic processing of
APP and characterization of the APP-cleaving enzymes (-,
-, and -secretases) have revealed important targets for
drug discovery, the regulation of APP trafficking is less well
understood. Several recent findings support the idea that the
intracellular transport and subcellular localization of APP
are crucial determinants of APP processing and A genera-
tion (4, 5). One pathway for A generation involves the rein-
ternalization of membrane-bound full-length APP (4, 5).
Endosomes have been shown to be intracellular compart-
ments, where the sequential action of - and -secretases
generates amyloidogenic COOH-terminal fragments of APP
(APP-CTFs) and A (1–3). APP is also targeted to and
degraded in the lysosomes (6). On the other hand, cleavage
within the A region of APP by -secretase, which prevents
the production of A, occurs in a late compartment of the
secretory pathway, such as the Golgi, or at the cell surface
(7). Deletion of the APP cytoplasmic tail or inhibition of
endocytosis has been shown to reduce A levels, suggesting
that endocytosis is critical for A generation (4, 5, 8). Under-
standing the mechanisms that regulate APP trafficking to
distinct subcellular compartments with the different secre-
tase activities is important for developing strategies to
reduce abnormal processing and to prevent A-induced
neurotoxicity.
Numb is an evolutionarily conserved protein identified by
its ability to control cell fate in the nervous system of Dro-
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sophila (11, 12). Numb contains two protein-protein inter-
action domains, a phosphotyrosine-binding domain (PTB)
and a proline-rich region (PRR) that functions as an Src
homology 3-binding domain (13, 14). Although only one
form of Numb has been identified in Drosophila, mammals
produce four alternatively spliced variants of Numb that dif-
fer in the length of their PTB (lacking or containing an 11-a-
mino acid insert) and PRR (lacking or containing a 48-amino
acid insert) domains (13, 14). All Numb proteins contain the
NPF (asparagine-proline-phenylalanine) and DPF (aspar-
tate-proline-phenylalanine) motifs that are critical for inter-
action with proteins containing the Eps15 homology domain
and with the clathrin protein AP-2, respectively. Numb can
associate with clathrin-coated pits, vesicles, and endosomes,
suggesting that it functions as an endocytic adapter protein
(15, 16). Numb plays a role in the internalization of receptors
that are involved not only in cell fate decisions during central
nervous system development (17) but also in neuronal mat-
uration, differentiation, and survival (18, 19). Notch is an
evolutionarily conserved transmembrane receptor that spec-
ifies cell fate in a wide variety of tissues and organisms through
local cell-cell interaction (20). Numb regulates the endocytic
and ubiquitin-dependent processing of Notch (21) and conse-
quently the cell fate decisions determined by Notch signaling
(22, 23). In maturing neurons, Numb binds to the neural adhe-
sion protein L1 and integrin in axonal growth cones and pro-
motes their recycling (24, 25).
Previous work has demonstrated an interaction between
APP and Numb in mouse brain lysates and in cell culture
(26). Truncation and site-directed mutagenesis studies have
shown that Numb binds to the YENPTY motif within the
intracellular domain of APP (26). Several other APP binding
partners that interact with this motif, including X11, Fe65,
mDab, C-Abl, and JIP-1, have been demonstrated to affect
endogenous APP localization and processing (27). Consider-
ing that Numb is an endocytic adapter protein, we deter-
mined whether expression of Numb influences the traffick-
ing and processing of APP. Our results show that expression
of Numb isoforms lacking the insert in the PTB (short PTB
(SPTB)-Numb) caused the abnormal accumulation of cellu-
lar APP in the early endosomes and increased the levels of
APP-CTFs. By contrast, expression of the Numb isoforms
with the insert in PTB (long PTB (LPTB)-Numb) causes a
significant reduction in the cellular content of APP and APP-
CTFs. Interestingly, when cultured primary cortical neurons
were subjected to trophic factor deprivation, the expression
of the SPTB-Numb increased at the expense of LPTB-Numb,
suggesting that pathophysiological conditions can alter
Numb isoform expression in a manner that increases amy-
loidogenic processing of APP. Understanding the function of
Numb in the trafficking of APPmay provide insights into the
regulation of APP processing in AD pathogenesis and lead to
possible AD therapies.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Antibodies used for immunode-
tection of APP were 6E10 (anti-A 1–17) and 22C11 (anti-
sAPP) (Chemicon), anti-amino terminus of APP (2.F2.19B4;
Chemicon), anti-carboxyl terminus of APP (APP 643–695),
and 4G8 anti-A (17–24) (Signet). The polyclonal antibodies to
Numb were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA) (sc-15590) or Upstate Biotechnology, Inc.
(anti-pan-Numb). The antibodies to Rab proteins were Rab5a
(Santa Cruz Biotechnology), Rab4a (Santa Cruz Biotechnol-
ogy), Rab11 (Santa Cruz Biotechnology), and Rab7 (Sigma).
LAMP-1 antibody was from Santa Cruz Biotechnology. Anti-
bodies to the following tags were GST (glutathione S-transfer-
ase; Cell Signaling), hemagglutinin epitope (Santa Cruz Bio-
technology), and FLAG epitope (Cell Signaling). Other
antibodies included ERK1/2 and phospho-ERK1/2 (Cell Signal-
ing), dynamin 1 (BD Biosciences), actin (Sigma), ubiquitin
(P4D1; Santa Cruz Biotechnology), transferrin receptor
(Zymed Laboratories Inc.), -secretase 1 (BACE1; Sigma), pre-
senilin-1 (PS1; Chemicon), nicastrin (Sigma), Aph-1 (Sigma),
and Pen-2 (Santa Cruz Biotechnology). Immunofluorescence-
conjugated secondary antibodies (Alexa Fluor 488-conjugated
goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-
goat IgG) were obtained from Molecular Probes. Additional
reagents included Lipofectamine Plus reagent (Invitrogen),
FuGENE-6 (Roche Applied Science), EZ-Link Sulfo-NHS-
LC-Biotin (Pierce), (DAPT; Calbiochem), lactacystin, peptide
aldehyde N-carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal
(MG-132), chloroquine (Calbiochem), and NH4Cl (Calbio-
chem). The ECL-Plus kit was obtained from Amersham Bio-
sciences. The -amyloid 1–40 and 1–42 colorimetric enzyme-
linked immunosorbent assay (ELISA) kit was purchased from
BIOSOURCE International Inc.
cDNA Constructs—Expression vectors for all four human
Numb isoforms have been described previously (28, 29). Full-
length Numb, PTB deletion mutants of human Numb, or con-
trol expression plasmids were constructed as in-frame fusions
downstream of the FLAG epitope. The plasmid for the domi-
nant negative dynamin (dyn 1K44E tagged to hemagglutinin
and enhanced green fluorescent protein) (30) was a kind gift
from Dr. N. Bunnett (University of California, San Francisco,
CA). The cDNA encoding dyn 1K44E was subcloned into the
retroviral vector pBabe-puro (Addgene). The construct was
transfected together with a plasmid encoding the vesicular
stomatitis virus membrane glycoprotein envelope into 293T
packaging cells (Clontech) using FuGENE-6, and the result-
ing virus-containing supernatant was collected at 48 and
72 h after transfection and used for transduction as
described (31). Expression of exogenous dyn 1K44E was con-
firmed by immunoblotting.
Cell Lines and Transfections—PC12, HEK293, and SH-SY5Y
cells were cultured under standard conditions in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum
(Invitrogen) and maintained at 37 °C in a 5% CO2, 95% air
atmosphere (32, 33). The PC12 cells stably expressing Numb
variants have been described previously (28). SY5Y neuroblas-
toma cells stably transfected with a construct carrying the AD
disease-linked double (“Swedish”) mutation K595N/M596L in
APP were obtained from Dr. W. Araki (National Institute of
Neuroscience, Tokyo, Japan).
Treatments—Trophic factor withdrawal (TFW) was accom-
plished by washing the cells twice with phosphate-buffered
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saline (PBS) and then maintaining them in Locke’s buffer (29,
32). DAPT (2 M) was used to inhibit -secretase activity. To
inhibit proteasomes and lysosomes, cells were treatedwith pro-
teasomal inhibitorsMG-132 (5mol/liter) and clasto-lactacys-
tin -lactone (5 mol/liter) or the lysosomal inhibitors chloro-
quine (100 mol/liter) and NH4Cl (50 mmol/liter) for various
time periods. Inhibitors were resuspended either in DMSO or
PBS. Controls were treated either with equivalent volumes of
DMSO for the proteasome inhibitors or with equivalent vol-
umes of PBS for chloroquine stimulations.
RNA Isolation and PCR—Total RNA from cells grown on
100-mm dishes was isolated with TRIzol (Invitrogen), and 2g
of RNA was reverse transcribed with Superscript II reverse
transcriptase and an oligo(dT) primer (32, 33). Quantitative
real time PCR analyses of APP, Numb, and actin were per-
formed using the following pairs of primers: rat APP, 5-CCA-
CTACCACAACTACCACTG-3 (forward) and 5-CCTCTC-
TTTGGCTTTCTGGAA-3 (reverse); rat -actin, 5-TGTGA-
TGGACTCCGGTGACGG-3 (forward) and 5-ACAGCTTC-
TCTTTGATGTCACGC-3 (reverse); Rab5A, 5-AACAAGA-
CCCAACGGGCCAAATAC-3 (forward) and 5-ATACACAA-
CTATGGCGGCTTGTGC-3 (reverse); PTB-Numb, 5-GGAA-
GTTCTTCAAAGGCTTCTTTG-3 (forward) and PTB-Numb
5-TTCATCCACAACTCTGAGTCCATC-3 (reverse). The
Numb primers were designed to flank the alternatively spliced
insert in the PTB of the rat Numb cDNA sequence (accession
number NM_133287).
SDS-PAGE and Western Blotting—Cells were harvested and
lysed in buffer (100 mM Tris, pH 6.8, 1% SDS, 10 mM EDTA, 5
mM EGTA, 2 mM phenylmethylsulfonyl fluoride, 25 g/ml leu-
peptin, 5 g/ml pepstatin). The lysates were cleared by centrif-
ugation at 13,000 g for 20min at 4 °C. The protein content of
cell lysates was measured using BCA reagent (Pierce). Extracts
containing 50 g of protein were electrophoresed using Tris-
HCl or 16.5% Tris-Tricine SDS-PAGE (Bio-Rad) under reduc-
ing conditions and immunoblotted onto nitrocellulose mem-
branes (Bio-Rad). For immunodetection of blots, enhanced
chemiluminescence (ECL; Amersham Biosciences) was
applied. The optical band densities were quantified using NIH
Image Analysis software.
Immunofluorescence Microscopy—Following experimental
treatments, cells were fixed for 20min in 4% paraformaldehyde
in PBS at room temperature, permeabilized (or not) with 0.2%
Triton X-100 in PBS, and incubated for 1 h in blocking solution
(0.2%TritonX-100, 5%normal horse or goat serum in PBS) and
thenwith primary antibody for 1 h in blocking solution at room
temperature (32, 33). The cells were washed with PBS and
finally incubated with 1 g/ml Alexa Fluor 488 goat anti-rabbit
IgG (1 g/ml; Molecular Probes) in blocking solution at room
temperature for 1 h. When double labeling was required, cell
preparations were incubated with Alexa Fluor 488-conjugated
anti-mouse IgG and rabbit Alexa Fluor 594-conjugated anti-
goat IgG (1:200). Immunostained cells were observed with the
appropriate filters on a Leica confocal laser-scanning micro-
scope; average pixel intensity per cell was determined using
software supplied by the manufacturer. Appropriate controls,
such as secondary antibody alone, indicated a lack of nonspe-
cific staining.
Measurements of sAPP Levels—For detection of sAPP, the
media were collected from cultures of PC12 clones and centri-
fuged at 3,500  g (10 min, 4 °C) to remove cell debris. The
cleared supernatants were concentrated at least 20-fold by
ultrafiltration. Cells were harvested, lysed, and prepared for
protein determinations. Equal amounts of volumes of superna-
tants, standardized to lysate protein, were subjected to SDS-
PAGE and immunoblotting analyses. All conditioned medium
values were normalized to total protein lysates.
A40/42 Sandwich ELISA—SH-SY5Y cells expressing the
Swedish mutant APP were transfected with plasmids for the
Numb variants or an empty pcDNA3 vector using Lipo-
fectamine reagent according to the manufacturer’s specifica-
tions. Conditioned media from transfected cells were collected
48 h after transfection, and protein inhibitors and 4-(2-amino-
ethyl)-benzenesulfonyl fluoride (Sigma) were added to prevent
the degradation of A. The concentration of A40/42 in sam-
ples and standards was measured in duplicates using the
-amyloid 1–40 and 1–42 colorimetric ELISA kit according to
the manufacturer’s instructions (BIOSOURCE). Similar meas-
urements of -amyloid 1–40 were performed in PC12 cells
subjected to TFW.
Measurements of Secretase Activity—The activity of APP
secretases was determined using commercially available secre-
tase kits (R&D Systems) according to the manufacturer’s pro-
tocol. The method is based on the secretase-dependent cleav-
age of a secretase-specific peptide conjugated to the fluorescent
reporter molecules EDANS and DABCYL, which results in the
release of a fluorescent signal that can be detected using a flu-
orescence microplate reader (excitation at 355 nm/emission at
510 nm). The level of secretase enzymatic activity is propor-
tional to the fluorimetric reaction.
Cell Surface Biotinylation—Confluent 10-cm dishes of each
of the PC12 clones were washed three times with ice-cold PBS
supplemented with 1 mM Ca2 and 2 mM Mg2 and incubated
with 1ml of biotin label (Pierce EZ-Link Sulfo-NHS-Biotin) at 2
mg/ml for 0.5 h on ice in the dark on a rotary mixer. The reac-
tion was stopped by extensive washing with PBS and quenched
with 50 mM glycine in PBS. Cell lysates were then immunopre-
cipitated with streptavidin-coated agarose. The precipitated
biotinylated proteinswere subjected to immunoblotting to ana-
lyze the content of APP and transferrin receptor.
Statistical Analyses—Statistical comparisons were made by
using Student’s t test and ANOVA with Scheffe post hoc tests
for pairwise comparisons.
RESULTS
Expression of Numb Proteins Alters APP Metabolism in a
Manner Dependent upon the PTB—To investigate the impact
of Numb on APP metabolism, we stably overexpressed each of
the four human Numb proteins in PC12 cells (28, 29). APP is
physiologically processed by -secretase or -secretase, result-
ing in the shedding of nearly the entire ectodomain to yield
large solubleAPPderivatives (called sAPP and sAPP, respec-
tively) and generation of membrane-tethered APP-CTFs that
include C83 and C99. The C99 is further cleaved by -secretase
to release the 4-kDa A peptide and the APP intracellular
domain. Stable expression of the SPTB-Numbproteins resulted
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in a significant accumulation of intracellular APP (Fig. 1A) and
increased secretion of sAPP and sAPP in the conditioned
media (Fig. 1B). By densitometric scanning of Western blots,
the total amount of APP holoprotein in cells overexpressing the
SPTB-Numb proteins was increased by 4–5-fold compared
with parental control cells and by 8–10-fold comparedwith the
LPTB-Numb clones.
The intracellular accumulation of APP holoprotein coin-
cided with a significant increase in the amount of APP process-
ing products. Both total sAPP and the amount of sAPP immu-
noprecipitated from the conditioned media with anti-APP
antibodies 22C11 and 6E10, respectively, were significantly
higher in the SPTB-Numb clones. Steady-state levels of the
-secretase- and -secretase-derived APP-CTFs, C83 and C99,
respectively, were also increased in lysates, consistent with the
ability of the SPTB-Numb proteins to promote nonamyloido-
genic and amyloidogenic processing pathways (Fig. 1B). The
opposite effect was observed in the clones expressing LPTB-
Numb; steady state levels of APP holoprotein andAPP process-
ing products were markedly reduced relative to the parental
clones. Only with long exposure times could the sAPP and
APP-CTFs in the LPTB-Numb clones be detected. In contrast
to APP, no change in the total levels of the transferrin receptor
(TfR) (Fig. 1A) was found in the lysates, suggesting that the
observed effects mediated by the Numb proteins were selective
for APP. Collectively, the data indicate that the Numb proteins
that differ in the PTB affect the processing of APP in a distinct
and contrasting manner.
Expression of Numb Proteins Alters AGeneration in aMan-
ner Dependent upon the PTB—Since the Numb proteins differ-
entially affect APP cleavage and the generation of APP-CTFs,
we reasoned that Numb should also influence the generation of
A. To test this notion, the cDNAs encoding FLAG-Numb
variants were transfected into SY5Y cells expressing the Swed-
ish mutant APP (Fig. 1C). A40 and A42 levels in the condi-
tioned medium 48 h after transfection were determined using
ELISA measurements. Consistent with the observed effects
of Numb on the generation of APP-CTFs, we found that the
LPTB-Numb proteins suppressed the production of A40
and A42 into the conditioned medium, whereas cells
expressing the SPTB-Numb proteins generated elevated lev-
els of A40 (7.3 versus 28.5 pg/ml/protein) and A42 (3.4
versus 13.2 pg/ml/protein) normalized to the total protein
amount (Fig. 1C).
Expression of the Numb Proteins Does Not Affect the Level of
APP Expression or the Proteolytic Activities of the APP-process-
ing Secretases—One possible explanation for the effects of
Numb on APP metabolism would be an alteration in the
expression of APP. The presence of the Numb proteins had no
significant effect on the levels of APPmRNA (Fig. 2A). We also
considered the possibility that the Numb proteins might differ-
entially alter the activities or the amounts of the APP-process-
ing secretases. To investigate the influence of the Numb pro-
teins on APP cleavages, we analyzed the proteolytic activities of
-, -, and -secretases using commercially available secretase
kits fromR&DSystems. No significant difference in the proteo-
lytic activities of these secretases was detected among the stable
clones (Fig. 2B). In addition, we found that levels of BACE1 and
of the -secretase components (presenilin-1, nicastrin, APH-1,
and APH2) (34) were not altered by the expression of Numb
(Fig. 2C), which further argued against a role of the Numb pro-
teins in regulating the proteolytic activities of the secretases.
Collectively, the data suggest that Numb proteins do not alter
APP metabolism by regulating the expression of APP or the
enzymatic activities of the secretases.
TheEffects ofNumbonAPPMetabolismAreDependent on Its
Interaction with APP and the Internalization of APP—Next, we
examined the interaction of the Numb proteins with APP to
determine whether isoform-specific interactions could explain
the contrasting effects of the Numb proteins on APP metabo-
FIGURE 1. Isoform specificity in the processing of APP and generation of
Aby theNumbproteins.A, effect ofNumbproteins on the amounts of APP
and TfR. Left, representative immunoblot showing total levels of APP and TfR
protein in the indicated PC12 clones. Each lane was loaded with 50 g of
protein. The relative amounts of APP and TfR were normalized to those of
actin. Densitometric analyses were performed on the immunoblots (right).
Thevalues in thehistogram represent themeanS.D.n3; *,p0.01; #,p
0.05 (ANOVAwith Scheffe post hoc tests) relative to empty vector-transfected
cells. B, effect of Numbproteins on the cleavage of APP. APPderivatives in the
conditionedmedium and in lysates of the indicated PC12 clones were quan-
tified byWestern blot followed by densitometric analyses. APP derivatives in
conditioned culture medium were immunoprecipitated with an antibody to
the amino-terminal domain of the APP protein (22C11), which precipitates
both sAPP and sAPP, and an antibody to A (6E10; Signet), which recog-
nizes sAPP. Steady-state levels of membrane-associated APP derivatives,
C99andC83,were immunodetectedwithantibodies to the carboxyl-terminal
domain of the APP protein. The-actin signal represents the internal loading
control. Densitometric analyses were performed on the immunoblots (left).
The values in the histogram represent the mean  S.D.; n  3; *, p  0.01;
#, p 0.05 (ANOVAwith Scheffe post hoc tests) relative to vector-transfected
control. Essentially similar results were obtained using two additional stable
clones. C, effect of Numb proteins on the generation of A peptides. SY5Y
cells stably expressing the Swedish mutation of APP were transfected with
plasmids encoding the FLAG-Numb proteins. Conditioned media were har-
vested and analyzed by a sandwich ELISA for specific quantitation of A40
and A42. Expression of FLAG-Numbproteins was detected by immunoblot-
ting using an antibody to FLAG (left). The histogram shows the amounts of
A40 and A42 in the indicated clones (right). The values represent the
mean S.D.;n3; *,p0.01; #,p0.05 (ANOVAwith Scheffepost hoc tests)
relative to vector-transfected cells.
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lism. Purified GST-fusion proteins of APP were mixed with
lysates of 293 cells expressing a Numb protein isoform, and
pull-down assays were performed. We found no differences in
the ability of each Numb protein to interact with the APP pro-
tein (supplemental Fig. 1). Because the interaction of APP with
Numb requires the YENPTY motif interacting with the PTB
(26), we determined the effects of a Numb deletion mutant
lacking the PTB (PTB-Numb) on APP metabolism. Quantifi-
cation of the Western blots (normalized to actin) revealed that
APP metabolism was not altered in the presence of the PTB-
Numb protein (Fig. 3A), suggesting that the PTB is required for
theNumbproteins to influenceAPPmetabolism.Todetermine
if theNumbproteins affect the proteolytic processing ofAPPby
targeting APP along the endocytic rather than the secretory
routes, we examined the effects of a dominant negative mutant
dynamin (dyn 1K44E tagged to the hemagglutinin epitope and
enhanced green fluorescent protein; a gift from N. Bunnett,
University of California, San Francisco, CA) on the ability of
eachNumb protein tomodulate APPmetabolism. TheGTPase
dynamin is an importantmediator of clathrin-dependent endo-
cytosis (35) and is required for the internalization of many cell
surface receptors including Notch (36) and APP (7). As
expected, inhibition of endocytosis by mutant dynamin
induced an elevation of APP holoprotein in all of the clones,
including the LPTB-Numb clones (Fig. 3B). Total APP protein
level in the SPTB-Numb and LPTB-Numb clones was not sig-
nificantly different compared with those in the vector-trans-
fected and parental clones. These results indicate that the
Numb proteins differentially affect the processing of APP along
the endocytic route.
Numb Proteins Influence the Endosomal Trafficking of APP—
APP undergoes a retrograde transport back to the cell body
wherein it is localized in Rab5a-positive early endosomes (37),
late endosomes (8, 38), lysosomes (6), and the Golgi complex
(8). To determine whether the Numb proteins affect the trans-
port of APP to these intracellular compartments, we applied
immunofluorescence microscopy to examine the subcellular
localization of APP and Numb. Both of these proteins are colo-
calized on the plasma membrane and in vesicular structures in
PC12 cells (Fig. 3C). Expression of the SPTB-Numb proteins
resulted in a marked accumulation of APP in enlarged endo-
somes (Fig. 3D) that were positively labeled for Rab5a (Fig. 3E).
Increased APP immunoreactivity was also detected in Rab11-
labeled recycling endosomes (data not shown) but not in
LAMP1-labeled lysosomal compartments of the SPTB-Numb
clones (data not shown). The subcellular location of APP was
similar to that of Numb, suggesting that Numb interacts with
APP in the early endocytic compartments. By contrast, APP
was only faintly detected in the Rab5-labeled (Fig. 3E),
Rab11-labeled, and LAMP1-labeled compartments (data not
shown) in LPTB-Numb clones. Collectively, these data sug-
gest that the PTB of Numb determines the processing fates
of APP by regulating its endosomal sorting and trafficking to
distinct compartments.
Effect of the Numb Proteins on the Endosomal Sorting of APP
to the Recycling Pathway—Despite the accumulation of APP in
the enlarged early endosomes (Fig. 3D), SPTB-Numb clones
exhibited increased release of sAPP and generation of C83,
suggesting that APPmay be preferentially sorted from the early
endosomes back to the cell surface, where APP is cleaved by
-secretase. To evaluate the amount of APP localized on the
cell surface, we performed cell membrane staining for APP on
ice without permeabilization. Only a small fraction of APP was
detected at the cell surface of parental cells not permeabilized
prior to antibody incubation (Fig. 4A), consistent with a previ-
ous report (5). The fraction of cell surface-bound APP was
markedly higher in the SPTB-Numb clones. As expected, this
fraction was significantly lower in the LPTB-Numb clones
compared with parental cells. As another measure of surface
APP protein level, proteins on the cell surface were biotinylated
with a cell-impermeant cross-linker, collected with neutravi-
din-coupled beads, and subjected to immunoblotting. As
expected, the level of biotinylated plasma membrane-bound
APP was significantly higher in SPTB-Numb clones (Fig. 4C).
By densitometric scanning ofWestern blots, the amount of cell
surface-localized APP relative to TfR was approximately 5-fold
higher in cells overexpressing SPTB-Numbcomparedwith vec-
tor-transfected cells (Fig. 4C). None of the biotinylated frac-
tions contained actin consistent with the labeling of only cell
surface-bound proteins (Fig. 4B).
FIGURE 2. Lack of isoform specificity on the expression of APP and the
activities of theAPP secretases. A, expression of the Numbproteins did not
alter the expression of APP. Left, semiquantitative real time PCR analysis of
APP mRNA in the indicated PC12 clones. The glyceraldehyde-3-phosphate
dehydrogenase signal represents the internal loading control. The values in
the histogram are the mean  S.D. of three independent measurements
(right). Essentially similar results were obtained using two additional stably
transfected clones. B, expression of the Numbproteins did not alter the activ-
ities of APP-processing secretases. The lysateswere tested for secretase activ-
ities by the addition of secretase-specific peptide substrates conjugated to
the reporter molecules EDANS and DABCYL (R&D Systems). Fluorescently
labeled peptides were detected only upon cleavage by the respective secre-
tases. After incubation at 37 °C for 2 h, reactions were transferred to a 96-well
plate, and fluorescencewasmeasured as described under “Experimental Pro-
cedures.” The values expressed as arbitrary units of fluorescence (AUF) are the
mean S.D. of at least three independent experiments.C, Numbproteins did
not alter the protein level of -secretase (BACE1) and of the components of
the -secretase complex. Representative immunoblots show total levels of
-secretase, presenilin-1, nicastrin, Aph-1, and Pen-2 in the indicated clones.
Each lane was loaded with 50 g of protein. Blots were reprobed with an
antibody against actin to confirm equal levels of protein loading among
samples.
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To determine whether vesicle recycling contributed to the
increased cell surface expression of APP in the SPTB-Numb
clone, we assessed the impact of a blockade in the endosome
recycling pathway. Preincubation withmonesin, an established
inhibitor of the recycling pathway that does not interfere with
the initial endocytosis of surface receptor proteins (43), signif-
icantly depleted cell surface APP expression, as assessed by sur-
face biotinylation followed by immunoblotting of the isolated
biotinylated fraction (Fig. 4D). The surface receptor-depleting
effect of monesin on TfR was only slightly reduced in the
absence of ligand (Fig. 4D), suggesting that the recycling path-
way of APP may be mechanistically distinct from that of TfR.
Quantification of the immunoblots revealed that the changes in
the ratio of APP to TfR after treatment with monesin was sig-
nificantly greater in the SPTB-Numb clone compared with the
vector-transfected cells (Fig. 4E).
Effect of the Numb Proteins on the
Endosomal Sorting of APP to the
Degradative Pathway—To further
establish that altered subcellular
localization of APP is responsible
for the differences in its processing
fates in theNumb clones, we treated
PC12 clones with chloroquine, a
weak base known to disrupt lysoso-
mal function by blocking organellar
acidification (42). Treatment with
chloroquine (100 M) for up to 6 h
(Fig. 5A) and longer (data not
shown) had no marked effects on
the levels of APP (Fig. 5A) and APP-
CTF derivatives (data not shown) in
SPTB-Numb clones. Similar results
were obtained in the presence of
ammonium chloride (NH4Cl; 50
mmol/liter), confirming that the
available pools of APP in the SPTB-
Numb cells were absent from the
lysosomes (Fig. 5B). By contrast, lev-
els of APP protein (Fig. 5A) and
APP-CTF derivatives (data not
shown) in LPTB-Numb clones were
significantly increased following
chloroquine treatment in compari-
son with vector-transfected cells,
ruling out the possibility that chlo-
roquine at the concentration of 100
Mwas too low to induceAPP accu-
mulation in the SPTB-Numb clone
(Fig. 5A). The same dose of chloro-
quine also caused marked accumu-
lation of APP and APP-CTFs in
SH-SY5Y cells stably transfected
with the empty vector or with the
Swedish mutant APP (Fig. 5C). The
effect of lysosomal inhibitors on
APP protein levels was dose-
dependent (data not shown). Con-
trol incubation of PC12 clones with PBS resulted in unchanged
levels of APP (data not shown). To determine that the chloro-
quine-induced increase in APP holoprotein was not related to
an effect of Numb on the synthesis of APP, we treated cells with
the protein synthesis blocker cycloheximide (10g/ml) in com-
bination with chloroquine. Treatment with cycloheximide for
6 h did not prevent the chloroquine-induced increase in APP
holoprotein (data not shown).
In contrast to lysosomal inhibitors, we found that treatment
with the -secretase inhibitor DAPT markedly enhanced
steady state levels of APP and APP-CTFs in the SPTB-Numb
clone (Fig. 5D). The APP-CTFs were only weakly detected in
the vector cells but became clearly visible, as in the untreated
SPTB-Numb clones, after treatment with DAPT, which halted
the cleavage of membrane-associated APP-CTFs. The effect of
DAPT on APP protein levels was dose-dependent (data not
FIGURE 3. Isoform specificity of Numbeffects onAPPmetabolism is dependent on the interaction of the
Numb proteins with APP and its subsequent internalization. A, expression of a Numb protein lacking the
PTB (PTB-Numb) did not alter APP metabolism. Left, representative immunoblot showing total levels of APP
holoprotein in the indicated PC12 clones. Each lanewas loaded with 50 g of protein. APP was quantified by
Western blot with an antibody to the amino-terminal domain of the APP protein, followed by densitometric
analyses (right). The relative amounts of APP were normalized to those of actin. B, inhibition of endocytosis by
overexpression ofmutant dyn 1K44E abolished the effects of the Numb proteins on APPmetabolism. Twenty-
four hours after transduction, cell lysates were analyzed by immunoblotting, followed by densitometry (right).
A representative immunoblot shows total levels ofAPP in the indicatedPC12clones.Overexpressionof thedyn
1K44E was confirmed using antibodies raised to dyn 1 and to the hemagglutinin tag. The -actin signal
represents the internal loadingcontrol. Thevalues in thehistogram represent themeanS.D.n3; *,p0.01;
#, p 0.05 (ANOVA with Scheffe post hoc tests) relative to vector-transfected cells. C, localization of APP and
Numb in PC12 cells by confocal immunofluorescence microscopy. Following fixation and permeabilization,
rabbit anti-Numb- and goat anti-rabbit-conjugated fluorescein isothiocyanate, mouse anti-APP (22C11), and
goat anti-mouse-conjugated CY3 secondary antibody were used to detect Numb and APP protein, respec-
tively. The right panel shows the merged image of APP and Numb. D, intracellular accumulation of APP and
membrane-associated APP derivatives in a SPTB-Numb (left) and LPTB-Numb clone (right). Following fixation
and permeabilization, APP was detected with antibodies to the amino- and carboxyl-terminal domains of the
APP protein. E, localization of APP to endocytic compartments by confocal immunofluorescence microscopy.
Following fixation and permeabilization, rabbit anti-Rab5A and goat anti-rabbit conjugated fluorescein iso-
thiocyanate were used to detect the early endosomes (green signal), and mouse anti-APP (22C11) and goat
anti-mouse-conjugated CY3 secondary antibody were used to detect APP protein (red signal). The right side of
each image shows themerged image of APP and Rab5, depicting early endosomes. The images are represent-
ative of those obtained from at least three stably transfected clones.
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shown). In contrast, DAPT failed to elevate levels of APP-CTFs
in the LPTB-Numb clones. Collectively, our data indicate that
theNumbproteins targetAPP to endocytic compartmentswith
distinct APP processing outcomes.
The Proteasome-mediated Degradative Pathway Is Not
Involved in the Regulation of APP Metabolism by the Numb
Proteins—Considerable evidence indicates that Numb antago-
nizes Notch signaling transduction by activating the endocytic
uptake and degradation of the Notch protein via the proteaso-
mal degradation pathway (21, 40). Because of the striking sim-
ilarities in the proteolytic processing of Notch and APP, we
hypothesized that the LPTB-Numb proteins may reduce APP
protein levels by facilitating proteasomal-mediated degrada-
tion of APP. To test this hypothesis, we treated the stable clones
with lactacystin, which inhibits proteasomal degradation of
proteins by specifically targeting the 20 S proteasome, without
interferingwith lysosomal protein degradation (41). Treatment
with lactacystin did not result in significant changes in APP
protein levels and did not impact the generation of APPmetab-
olites in any of the clones tested (Fig. 5E), suggesting that the
differential effects of the Numb proteins on APP metabolism
did not involve the ubiquitin-proteasome protein degradation
pathway. Higher concentrations of lactacystin did not signif-
icantly induce APP accumulation, although the dose of 10
M was sufficient to induce enrichment of ubiquitinated
protein species in general, as
shown in Western blot analysis
conducted with an antibody to
ubiquitin (data not shown). Col-
lectively, the data indicate that the
drastic reduction in APP protein
level in the LPTB-Numb clones
was not due to Numb-mediated
targeting of APP for proteasome-
dependent degradation.
Expression of Numb Proteins
Alters the Levels of the Rab Family of
Endocytic Regulators—Recent stud-
ies have demonstrated the involve-
ment of GTP-binding proteins of
the Rab family in the trafficking and
processing of APP (44, 45). Rab pro-
teins are localized in both discrete
organelles and vesicles, where they
play key roles in protein trafficking
between compartments along the
secretory and endocytic routes. To
determine whether the differential
endosomal sorting of APP resulted
from the altered expression of Rab
proteins, we measured protein lev-
els of Rab4, Rab5A, Rab7, and
Rab11. Rab5A is a small GTPase
localized on early endosomes and
controls endosome fusion along the
endocytic pathway. Rab4A and
Rab11 are regulators of the recy-
cling endosomes (44, 45). Protein
levels of Rab4A, Rab5A, and Rab11 were significantly increased
in the SPTB-Numb clones relative to control cells (Fig. 6,A and
B). By contrast, levels of Rab5A and Rab11 were decreased in
the LPTB-Numb clones relative to control cells (Fig. 6, A and
B). Levels of Rab7, a regulator of fusion events in the late endo-
cytic pathway, and of LAMP-1 (lysosome-associated mem-
brane protein-1) were not different among the stable clones
(Fig. 6, A and B). The changes in the level of the Rab5A protein
were not attributable to altered expression, since its mRNA
level was not significantly different in the stably transfected
Numb clones (Fig. 6C).
Stress Induces the Selective Up-regulation of SPTB-Numb
Transcripts—It has been previously reported that alternative
splicing of Numb primary transcripts is developmentally regu-
lated (45, 46). To determine whether the balance of the alterna-
tive spliced variants of Numb might be disrupted in cells that
were stimulated by apoptosis-inducing agents, we designed oli-
gonucleotide primers that bind to the flanking sequences of the
insertion in the PTB (Fig. 7A). The expected sizes of the ampli-
fied PCR products for the SPTB- and LPTB-Numb transcripts
were 114 and 147 base pairs, respectively. The level of LPTB-
Numb mRNA that is predominantly expressed under basal
condition decreased rapidly upon TFW, an insult that has pre-
viously been shown to alterNumbexpression (29), whereas that
of SPTB-Numb accumulated concomitantly in stressed cells
FIGURE 4. Effect of the Numb proteins on the sorting of APP to the recycling pathway. A, the Numb
proteins differentially alter the amount of cell surface APP. Immunostaining of cell surface APP with an anti-
body to theamino-terminal endofAPP is shown. Innonpermeabilized cells (without TritonX-100), significantly
more APP is detected on the surface of a SPTB-Numb clone compared with a LPTB-Numb clone or a clone
transfectedwith empty vector.B, detectionof cell surfaceAPPbybiotinylation. Cellswere surface-biotinylated,
lysed, and incubated with streptavidin-agarose beads. Biotinylated proteins were immunoblotted with anti-
bodies toAPP andTfR.C, quantitative data showing the ratio of cell surfaceAPP andTfR in the indicated clones.
Values are the mean S.D. of at least three independent experiments. *, p 0.01; #, p 0.05 (ANOVA with
Scheffe post hoc tests) relative to vector-transfected cells. D, recycling blockade depletes cell surface APP
protein level. The indicated clones were pretreated with monensin for 60 min at 37 °C in Dulbecco’s modified
Eagle’s medium/bovine serum albumin and incubated in Dulbecco’s modified Eagle’s medium/bovine serum
albumin for 60 min afterward. Cells were then surface-biotinylated using a membrane-impermeable cross-
linker and immunoprecipitated with streptavidin beads. Precipitates were subjected to SDS-PAGE, and blots
were probed with antibodies to APP and TfR. E, quantitative data showing the changes in the ratio of cell
surface APP and TfR in the vector-transfected and a SPTB-Numb clone after monesin treatment. Values are
plotted as percentage of untreated control (vehicle) and are the mean  S.D. of at least three independent
experiments. *, p 0.05 (Student’s t test) relative to vector-transfected cells.
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(Figs. 7,B andC). Protein but notmRNA levels ofAPPwere also
increased in PC12 cells subjected toTFW(Fig. 7D). TFWmark-
edly increased the production of A 1–40 (Fig. 7E). Collec-
tively, these data suggest that cellular stress could induce the
selective up-regulation of SPTB-Numb proteins, which pre-
cedes the accumulation of APP protein. The stress-induced
changes in Numb isoform expression and the subsequent
Numb isoform-dependent effect on APP trafficking and proc-
essing are schematically summarized in Fig. 8.
DISCUSSION
Alterations in the endosomal-lysosomal system are believed
to occur early in the disease process inAD, andmay precede the
formation of plaques and tangle-associated neuropathology in
susceptible neuron populations. Endosome enlargement
occurs early in sporadic AD, and is associated with increased
endocytosis and endosome recy-
cling. A immunoreactivity is evi-
dent in these populations of
enlarged endosomes prior to A
deposition indicating their potential
importance for A formation in
early AD brain. Much attention has
focused on the mechanisms that
regulate the trafficking of APP to
endosomes. In this study, we have
uncovered a novel function for the
Numb adapter proteins as a regula-
tor of endocytic trafficking of APP.
Most surprisingly, we found that the
Numb proteins that differ in the
PTB, but not in the PRR domain,
have opposite effects on the trans-
port and processing of APP. The
expression of SPTB-Numb proteins
resulted in a significant accumula-
tion and persistence of APP holo-
protein in the early endosomes and
increased A secretion. By contrast,
expression of LPTB-Numb proteins
significantly decreased the accumu-
lation of APP and inhibits A secre-
tion. The reduction in A secretion
was not the result of either the
decreased expression of APP or a
significant reduction in the activi-
ties of the APP processing secreta-
ses. Furthermore, we demonstrated
that all the Numb isoforms were
capable of interacting with the APP
holoprotein, as reported by a previ-
ous study (26). The APP-lowering
effect was related to the trafficking
role of the LPTB-Numb proteins
along the endocytic rather than the
secretory pathway as treatment
with lysosomal inhibitors was able
to restore endogenous APP holo-
protein to the steady state level found in vector-transfected
cells. It is conceivable that LPTB-Numb but not SPTB-Numb
proteins facilitate the delivery of APP to the lysosomes for deg-
radation by acidic hydrolases. Taken together, these results
indicate that APP trafficking differs strikingly in the clones sta-
bly expressing the Numb proteins and raise the intriguing pos-
sibility that alternative splicing of Numb could alter the traf-
ficking of APP and, concomitantly, its processing fate.
Numb was discovered as an intracellular Notch antagonist
(17, 19). Considerable evidence over the past years has indi-
cated that Numb antagonizes Notch1 signaling by inducing
Notch1 ubiquitination and endocytic degradation of NICD (21,
41). Genetic and biochemical evidence in invertebrates has sug-
gested that proteasomal degradation of Notch may be required
for the cessation of Notch signaling (21, 41). Numb has been
shown to recruit the E3 ubiquitin ligase to facilitate Notch
FIGURE 5.Effect of theNumbproteins on the sortingofAPP to thedegradativepathway.A, time course of
the accumulation of APP and APP-CTFs in LPTB-Numb but not SPTB-Numb clones after treatment with a
lysosomal inhibitor. The indicated stable PC12 clones were treated with choroquine (100 M) for 0, 2, and 6 h.
Equal amounts of cellular lysates were separated by 16.5% Tris-Tricine SDS-PAGE and immunoblotted with an
antibody to the carboxyl terminus of APP. -Actin was used as the internal loading control. Densitometric
analyses were performed on the immunoblots (bottom). The values in the histogram are the mean S.D. of
three independent measurements. *, p  0.01; #, p  0.05 (ANOVA with Scheffe post hoc tests) relative to
vector-transfected cells. Similar results were obtained using two additional stably transfected Numb clones.
B, time course of the accumulation of APP in LPTB-Numb but not SPTB-Numb clones upon treatment with
NH4Cl. The indicated clones were treated with NH4Cl (50 M) for 0, 2, 6, and 8 h and processed for immuno-
blotting using an antibody to the carboxyl-terminal of APP. C, time course of the accumulation of APP and
APP-CTFs in SH-SY5Y cells overexpressing the empty vector (Vector) or a vector encoding the Swedishmutant
APP (APP) upon chloroquine treatment. The indicated SY-SY5Y clones were treated with choroquine (100M)
for 0, 2, and 6 h. Each lanewas loaded with 50 g of protein. -Actin was used as the internal loading control.
D, time course of the accumulation of APP in the SPTB-Numb but not LPTB-Numb clones after treatment with
the -secretase inhibitor DAPT. The indicated clones were treated for 0, 2, 6, and 12 h with 10 M DAPT. Each
lanewas loadedwith 50gof protein.-Actinwasused as the internal loading control. Densitometric analyses
were performed on the immunoblots (bottom). Values are the means S.D. of three independent measure-
ments. *,p0.01 (ANOVAwith Scheffepost hoc tests) relative to empty vector-transfected cells. E, inhibitionof
the proteasomes failed to affect the regulation of APP metabolism by the Numb proteins. Time course of the
levels of APP and APP-CTFs in the indicated clones after treatment with 10 M lactacystin. Equal amounts of
protein from each samplewere immunoblotted to detect APP and APP-CTFs. Each lanewas loadedwith 50g
of protein and verifiedwith an antibody to actin. Essentially similar results were obtained using two additional
stably transfected Numb clones.
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receptor ubiquitination (21). Several E3 ubiquitin ligases, such
as LNX, Itch, Siah1, and Mdm2, have been shown to associate
with Numb (21, 47–49). To exclude the possibility that LPTB-
Numb targets APP for proteasomal degradation, we found that
proteasomal inhibition had no marked effect on the accumula-
tion of APP in the stable clones examined, suggesting that
Numb did not target APP for proteasomal degradation.
The PTB is a protein-protein interaction motif that has been
identified in a diverse group of proteins, of which only a subset
is linked to tyrosine kinase-mediated signaling (50). Structure-
function analyses indicated that the Numb PTB can bind to
multiple conformationally distinct peptide ligands in a phos-
photyrosine-independent manner (51–53). The PTB of Numb
has been shown to interactwith diverse proteins that determine
its subcellular localization (54) and protein stability (55). The
PTB of Numb mediates the interaction with the E3 ubiquitin
ligases responsible for the ubiquitination of its bound sub-
strates, such as Notch and Gli (17, 21). Hence, the presence or
absence of the insertion within the PTB could impact the inter-
action of the Numb proteins with E3 ligases and the targeted
substrates (17, 56). We found that the insert in the PTB did not
affect the ability of the Numb proteins to interact with APP, in
accord with a previous study showing that APP was found in
complex with all four mammalian Numb isoforms in cortical
lysates (26). Furthermore, the insert of the PTB did not alter the
subcellular localization of the Numb proteins (28, 29), suggest-
ing that the differential effects of the Numb proteins on APP
metabolism could not be attributed to the preferential targeting
of LPTB-Numb proteins to membrane-bound APP. The pres-
ent study showed that Numb can bind directly to the YENPTY
motif in the cytoplasmic domain of APP (supplemental Fig. 1),
an interaction that is not only required for the internalization of
cell surface APP but also for its subsequent transport and proc-
essing fate (57).
The accumulation of APP holoprotein did not correlate with
a reduction ofA secretion,which supports the contention that
the Numb proteins influence the trafficking of endogenous
APP along endocytic rather than secretory routes. Additional
data showed that inhibition of endocytosis by overexpression of
a dominant-negative dynamin negates the observed effects of
the Numb proteins on APP metabolism. Furthermore, treat-
ment of the Numb clones with brefeldin A to inhibit the trans-
port of proteins from the endoplasmic reticulum to the Golgi
did not show any effect onAPP accumulation (data not shown),
whereas lysosomal inhibitors restored steady state levels ofAPP
in the LPTB-Numb clones (Fig. 5).
The reduced sensitivity of the SPTB-Numb clones to inhibi-
tion of lysosomal degradation suggests that these Numb pro-
teinsmay interfere with the transport of APP to the degradative
pathway. Alternatively, we cannot rule out the possibility that
these Numb proteins play an active role in recycling internal-
ized APP back to the cell surface. This notion is consistent with
the increased amounts of released sAPP and intracellular C83
generated by -secretase cleavage, which occurs mainly at the
cell surface. Since dissociation of protein-protein complexes
favors the recycling pathway, it remains to be elucidated
whether the interaction of the Numb proteins and APP results
in conformational changes that are differentially resistant to
decreasing pH values within the endosomal pathway. Regard-
less of the underlying molecular mechanisms, our data suggest
that the Numb proteins differentially alter the endocytic traf-
ficking of APP by regulating the endosomal sorting of this pro-
tein either to the degradative or recycling pathway. It will be
interesting to examine whether the Numb proteins differen-
tially affect the trafficking of other receptorswith the conserved
YENPTYmotif, such as TrkA, a tyrosine kinase receptor whose
protein level and responsiveness to nerve growth factor were
shown to be differentially affected by the Numb proteins (28).
Whether the Numb proteins are directly involved in the
active transport of APP remains to be elucidated. Intracellular
trafficking through the endocytic and recycling pathway is reg-
ulated by the small GTPase Rab proteins, whose altered expres-
sion and activity has been linked to altered APPmetabolism (9,
10, 44). Rab5A up-regulation is associated with enlarged early
endosomes and intracellular accumulation of APP (9). Altered
Rab5A activity is responsible for the early abnormalities of the
neuronal endocytic pathway that are directly related to a rise in
A levels in the brains of AD patients (9, 10). Previous studies
demonstrated that Numb interacts with Arf6 and EHD4 (58),
proteins that have been associated with the recycling of plasma
membrane proteins internalized by clathrin-dependent and
clathrin-independent endocytic routes (59). Impairments in
FIGURE 6. Effect of theNumbproteins on the levels of small RabGTPases.
A, representative immunoblots showing total amounts of Rab4A, Rab5A,
Rab7, Rab11, and LAMP1 in the indicated clones. Each lane was loaded with
50g of protein and verifiedwith an antibody to actin. B, densitometric anal-
yses were performed on the immunoblots shown in A. The values in the his-
togramare themean S.D. of three independentmeasurements. *, p 0.01;
#, p 0.05 (ANOVAwith Scheffe post hoc tests). C, semiquantitative real time
PCR analysis of Rab5A mRNA in the indicated PC12 clones. The glyceralde-
hyde-3-phosphate dehydrogenase signal represents the internal loading
control.
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the sorting pathway could also
account for the intraneuronal A
accumulation in the brains of APP
mutant transgenic mice and
human AD patients (60). We
found that level of Rab5A protein
but not mRNA was elevated in the
SPTB-Numb clones, suggesting
that altered Rab5A function in
part correlates specifically with
altered trafficking of APP. The
mechanism(s) whereby expression
of SPTB-Numb increases protein
level of Rab5A but not mRNA
remains to be established.
At present, the factors that regu-
late the alternative splicing of the
primary Numb transcript are not
known. It has been shown that the
four Numb isoforms are temporally
regulated and implement distinct
developmental functions (45, 46).
Ectopic expression of Numb iso-
forms lacking the PRR insertion
promotes differentiation, whereas
those isoforms with the insertion
direct proliferation. Indeed, the
expression of LPRR-Numb isoforms
that promote proliferation peaks
during the expansion of the neural
progenitor pool but is down-regu-
lated during the course of neuronal
development (45, 46). The expres-
sion pattern of the Numb proteins
also varies dramatically between
different tissues and cultured cell
lines, suggesting that Numb iso-
forms may have different functions
in different cell types. Our previous
study demonstrated that Numb
protein levels increased inA-laden
brain regions of a mouse model of
AD (29). In this study, we found for
the first time that pathophysiologi-
cal conditions can up-regulate the
expression of SPTB-Numb at the
expense of LPTB-Numb. This find-
ing raises the intriguing possibility
that altered Numb expression is an
early pathologic event that may be
responsible for increased A pro-
duction in patients with AD.
Although the exact function of
APP is still not resolved, experimen-
tal evidence suggests several activi-
ties, including synaptogenesis, neu-
rite outgrowth, and cell survival in
neurons (1). All of these activities
FIGURE 7.Detection of alternatively spliced Numb transcripts under normal and stressed conditions.
A, domain structure of the Numb protein. The 11-amino acid insertion in the PTB is indicated in black. The
forward (F) and reverse (R) primers were designed to amplify a region flanking the PTB insertion. The
specificity of the primer set was confirmed by performing PCR using an empty plasmid (pCDNA3.1) or
plasmids containing each of the four Numb isoforms. The expected sizes of PCR fragments were 114 and
147 base pairs for the SPTB- and LPTB-Numb transcripts, respectively. B, time course of SPTB-Numb and
LPTB-NumbmRNA levels in PC12 cells subjected to TFW. C, densitometric analyses were performed on the
data shown B. The values in the histogram are themean S.D. of three independentmeasurements. *, p
0.01 (Student’s t test) relative to untreated control PC12 cells. D, effect of stress-induced Numb isoform
change on APP processing. Top, semiquantitative real time PCR analysis of APP mRNA levels in PC12
before and after TFW for the indicated times. The glyceraldehyde-3-phosphate dehydrogenase signal
represents the internal loading control. Bottom, representative immunoblots showing total levels of APP
in PC12 cells left untreated (Con) or subjected to TFW for 24 h. Each lane was loaded with 50g of protein.
-Actin was used as the internal loading control. Densitometric analyses were performed on the immu-
noblots. The values in the histogram represent the mean  S.D. of three independent measurements.
*, p 0.05 (Student’s t test) relative to nontreated cells. E, effect of stress-induced Numb isoform change
on the generation of A. PC12 cells were left untreated (Con) or subjected to TFW for 24 h. Conditioned
media were harvested and analyzed by a sandwich ELISA for specific quantitation of A40. The histogram
shows the relative amounts of A40. The values represent the mean S.D.; n 3; *, p 0.01 (Student’s t
test) relative to nontreated control cells.
FIGURE 8. Summary diagram showing the effects of the alternatively spliced Numb isoforms on the
trafficking and processing of APP.
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may potentially be affected by the presence of Numb proteins
determining the processing fates of APP. Of particular note is
that overexpression of SPTB-Numb in PC12 cells enhanced
neurite outgrowth (28) and increased vulnerability to apoptotic
stimuli by a mechanism dependent on the dysregulation of
intracellular Ca2 homeostasis (28, 29). HowNumbmodulates
intracellular Ca2 homeostasis remains to be elucidated. The
disruption in Ca2 signaling may be linked to altered APP
metabolism (1, 39), suggesting the involvement of altered
Numb function or expression in the genesis of the AD pheno-
type. Hence, perturbation of Numb expression may have
important implications for AD pathogenesis.
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